These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10360211)

  • 1. Implantable defibrillator recipients' responses to device implantation and design.
    Pelletier D; Mitten-Lewis S; Gallagher RD; McKinley S; Squire J
    Biomed Instrum Technol; 1999; 33(3):224-9. PubMed ID: 10360211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian implantable cardiac defibrillator recipients: quality-of-life issues.
    Pelletier D; Gallagher R; Mitten-Lewis S; McKinley S; Squire J
    Int J Nurs Pract; 2002 Apr; 8(2):68-74. PubMed ID: 11993579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods of ambulatory detection and treatment of cardiac arrhythmias using implantable cardioverter-defibrillators.
    Shrivastav M
    Biomed Instrum Technol; 1999; 33(6):505-21. PubMed ID: 10626042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Living with an implantable cardioverter defibrillator: patient outcomes and the nurse's role.
    Sossong A
    J Cardiovasc Nurs; 2007; 22(2):99-104. PubMed ID: 17318034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes, problems and quality of life with the implantable cardioverter defibrillator.
    Reid SS; McKinley S; Nagy S
    Aust J Adv Nurs; 1999; 16(4):14-9. PubMed ID: 10603767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Hosting" an implantable cardioverter defibrillator: A phenomenological inquiry.
    Garrino L; Borraccino A; Peraudo E; Bobbio M; Dimonte V
    Res Nurs Health; 2018 Feb; 41(1):57-68. PubMed ID: 29171061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the use of implantable cardioverter defibrillators in Australia: a 10-year nationwide study from 2000-2009.
    Burch AW; Wong CX; Sullivan T; Brooks AG; Leong DP; Lau DH; Sun MT; Roberts-Thomson KC; Sanders P
    Intern Med J; 2013 Aug; 43(8):888-95. PubMed ID: 23734916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden Death in Patients With Cardiac Implantable Electronic Devices.
    Tseng ZH; Hayward RM; Clark NM; Mulvanny CG; Colburn BJ; Ursell PC; Olgin JE; Hart AP; Moffatt E
    JAMA Intern Med; 2015 Aug; 175(8):1342-50. PubMed ID: 26098676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current status of implantable cardioverter defibrillator].
    Iturralde Torres P
    Arch Cardiol Mex; 2002; 72 Suppl 1():S86-90. PubMed ID: 12001878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
    Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
    Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiological and psychosocial status of patients with malignant ventricular arrhythmias before implantation of a cardioverter defibrillator. First results from the German Austrian ICD Multicenter Study (GAIMS)].
    Herrmann-Lingen C; Fritzsche K; Kanwischer H; Drinkmann A; Rabung S; Bergmann G;
    Psychother Psychosom Med Psychol; 2004 Aug; 54(8):308-19. PubMed ID: 15284942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recipients' of implanted cardioverter-defibrillators actual and perceived adaptation: a review of the literature.
    Zayac S; Finch N
    J Am Acad Nurse Pract; 2009 Oct; 21(10):549-56. PubMed ID: 19796289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after implantable cardioverter-defibrillator implantation in the elderly.
    Yung D; Birnie D; Dorian P; Healey JS; Simpson CS; Crystal E; Krahn AD; Khaykin Y; Cameron D; Chen Z; Lee DS
    Circulation; 2013 Jun; 127(24):2383-92. PubMed ID: 23775193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological impact of implantable cardioverter defibrillator on their recipients.
    Wheeler EC; Pretzer-Aboff I; Hardie T; Disabatino A; Saylor J; Lucey R
    Dimens Crit Care Nurs; 2009; 28(4):176-81. PubMed ID: 19546727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The quality of life after the implantation of a cardioverter/defibrillator in malignant arrhythmias].
    Lüderitz B; Jung W; Deister A; Marneros A; Manz M
    Dtsch Med Wochenschr; 1993 Mar; 118(9):285-9. PubMed ID: 8444109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?
    Germano JJ; Reynolds M; Essebag V; Josephson ME
    Am J Cardiol; 2006 Apr; 97(8):1255-61. PubMed ID: 16616037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and efficacy of classic ambulatory implantable cardioverter-defibrillator and resynchronisation systems follow-up compared to telemetric follow-up].
    Lelakowski J; Rydlewska A; Piekarz J; Lelakowska-Pieła M; Pudło J
    Pol Merkur Lekarski; 2016 Mar; 40(237):153-9. PubMed ID: 27088195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.